Search is Powered by Google
Cancer / Oncology News

Major scientific discovery in cancer research to be honored

Main Category: Cancer / Oncology
Article Date: 24 Jul 2004 - 7:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

Nominations open for 2005 Pezcoller Foundation-American Association for Cancer Research
International Award for Cancer Research

Scientists involved in cancer research, cancer medicine or cancer-related biomedical science can nominate a colleague or professional associate whom they believe has advanced significantly the understanding of cancer and whose work holds promise for future contributions for the field for the 8th Pezcoller Foundation-American Association for Cancer Research International Award for Cancer Research.

The nomination process and other details about the award located on the AACR Website at
http://www.aacr.org. The deadline for nominations is Friday, September 17, 2004.

The award is intended to honor an individual scientist for his or her highly original research. In order to be eligible, candidates must be recently published, active researchers, working in academia, industry or government anywhere in the world.
The winner will give an award lecture during the 96th AACR Annual Meeting in Anaheim, Calif., April 16-20, 2005, and will officially receive the award of €75,000 and a commemorative plaque at a May 2005 ceremony in Trento, Italy, where the Pezcoller Foundation is located.

Past recipients of the Pezcoller Foundation-AACR International Award for Cancer Research are:

2004:
Stanley J. Korsmeyer, M.D.
Sidney Farber Professor of Pathology and Professor of Medicine
Dana-Farber Cancer Institute, Harvard Medical School, Boston, Mass.
Investigator, Howard Hughes Medical Institute

2003:
Mario R. Capecchi, Ph.D.
Distinguished Professor and Co-chairman
Eccles Institute of Human Genetics
University of Utah, Salt Lake City

2002:
Carl-Henrik Heldin, Ph.D.
Director, Ludwig Institute for Cancer Research
Professor of Molecular Cell Biology
Uppsala University, Uppsala, Sweden

The Pezcoller Foundation was established in 1982 by Professor Alessio Pezcoller, a dedicated Italian surgeon who made important contributions to medicine during his career and who, through his foresight, vision, and generous gift in support of the formation of the Foundation, stimulated others to make significant advances in cancer research. The Foundation sponsors a series of symposia and publishes a journal. In the past, the Pezcoller Foundation gave a biennial award for contributions to cancer and cancer-related biomedical science in collaboration with the European School of Oncology. The Pezcoller Foundation-AACR International Award builds upon this tradition

Founded in 1907, the American Association for Cancer Research (AACR) is a professional society of more than 22,000 laboratory and clinical scientists engaged in basic, translational, and clinical cancer research in the United States and over 60 other countries. The AACR's mission is to accelerate the prevention and cure of cancer through research, education, communication, and advocacy. Its principal activities include the publication of five major peer-reviewed scientific journals (Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; and Cancer Epidemiology, Biomarkers & Prevention). The AACR's Annual Meeting attracts more than 15,000 participants who share new and significant discoveries in the cancer field, and the AACR's specialty meetings throughout the year focus on all the important areas of basic, translational, and clinical cancer research.

Contact: Elizabeth Tait
tait@aacr.org
215-440-9300
American Association for Cancer Research




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
Shocking Pictures To Appear On Cigarette Packets In UK On 1st October
27 Sep 2008
The UK's ten million Smokers may see pictures of rotting teeth, throat cancer, and indications of male impotence (erectile dysfunction) on cigarette packets they buy at the beginning of October...


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

View more videos...